ijms-logo

Journal Browser

Journal Browser

Understanding the Mechanisms of Mitochondrial Stress and Its Association with Human Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 959

Special Issue Editor


E-Mail Website
Guest Editor
Soonchunhyang Institute of Medi-Bio Science (SIMS), Soonchunhyang University, Cheonan 31151, Republic of Korea
Interests: mitochondrial stress; integrated stress response; metabolic diseases; neurodegenerative diseases

Special Issue Information

Dear Colleagues,

Mitochondria are essential organelles responsible for the production of energy in the form of ATP in eukaryotic cells. In addition to energy production, mitochondria play a crucial role in various cellular processes, such as calcium signalling, heme biosynthesis, the synthesis and breakdown of lipids and amino acids, and the regulation of programmed cell death. Therefore, the maintenance of mitochondrial integrity is important for optimal cellular function and the prevention of the development of diseases associated with mitochondrial dysfunction. Mitochondrial stress is the impairment of the normal function of mitochondria caused by various factors such as oxidative stress, mitochondrial DNA mutations, and impaired mitochondrial proteostasis. Mitochondrial stress can lead to mitochondrial dysfunction, which has been implicated in various human diseases, including neurodegenerative disorders, metabolic diseases, cardiovascular diseases, and cancers. Therefore, cells develop defensive systems to recover the mitochondrial function upon mitochondrial stress, which can mitigate the effects of mitochondrial dysfunction. Some of the key mitochondrial stress responses are mitochondrial biogenesis, the regulation of mitochondrial dynamics, mitophagy, and the mitochondrial unfolded protein response (UPRMT). These responses aim to restore normal mitochondrial function, clear damaged mitochondria, and prevent further damage. Understanding the underlying mechanisms of the mitochondrial stress response is essential for the development of therapeutic approaches to treat diseases associated with mitochondrial stress and dysfunction.

This Special Issue will cover a selection of recent research topics and current review articles related to the underlying mechanisms in mitochondrial stress and its association with human diseases. The topics of interest include, but are not limited to:

1. Mechanisms of mitochondrial stress and its effects on cellular processes.

2. Mitochondrial stress and its association with human diseases such as neurodegenerative disorders, metabolic diseases, cardiovascular diseases, and cancer.

3. Diagnostic tools and biomarkers for assessing mitochondrial stress and dysfunction.

4. Therapeutic approaches to mitigate the effects of mitochondrial stress and prevent the development of associated human diseases.

5. Mitochondrial stress and its association with ageing and age-related diseases

Dr. Jaeseok Han
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondrial stress
  • mitochondrial quality control
  • mitophagy
  • mitochondrial unfolded protein response
  • mitochondrial fission and fusion
  • mitochondria-related diseases

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

30 pages, 10649 KiB  
Article
An In Silico Analysis of Genetic Variants and Structural Modeling of the Human Frataxin Protein in Friedreich’s Ataxia
by Loiane Mendonça Abrantes Da Conceição, Lucio Mendes Cabral, Gabriel Rodrigues Coutinho Pereira and Joelma Freire De Mesquita
Int. J. Mol. Sci. 2024, 25(11), 5796; https://doi.org/10.3390/ijms25115796 - 26 May 2024
Viewed by 447
Abstract
Friedreich’s Ataxia (FRDA) stands out as the most prevalent form of hereditary ataxias, marked by progressive movement ataxia, loss of vibratory sensitivity, and skeletal deformities, severely affecting daily functioning. To date, the only medication available for treating FRDA is Omaveloxolone (Skyclarys®), [...] Read more.
Friedreich’s Ataxia (FRDA) stands out as the most prevalent form of hereditary ataxias, marked by progressive movement ataxia, loss of vibratory sensitivity, and skeletal deformities, severely affecting daily functioning. To date, the only medication available for treating FRDA is Omaveloxolone (Skyclarys®), recently approved by the FDA. Missense mutations within the human frataxin (FXN) gene, responsible for intracellular iron homeostasis regulation, are linked to FRDA development. These mutations induce FXN dysfunction, fostering mitochondrial iron accumulation and heightened oxidative stress, ultimately triggering neuronal cell death pathways. This study amalgamated 226 FXN genetic variants from the literature and database searches, with only 18 previously characterized. Predictive analyses revealed a notable prevalence of detrimental and destabilizing predictions for FXN mutations, predominantly impacting conserved residues crucial for protein function. Additionally, an accurate, comprehensive three-dimensional model of human FXN was constructed, serving as the basis for generating genetic variants I154F and W155R. These variants, selected for their severe clinical implications, underwent molecular dynamics (MD) simulations, unveiling flexibility and essential dynamic alterations in their N-terminal segments, encompassing FXN42, FXN56, and FXN78 domains pivotal for protein maturation. Thus, our findings indicate potential interaction profile disturbances in the FXN42, FXN56, and FXN78 domains induced by I154F and W155R mutations, aligning with the existing literature. Full article
Show Figures

Figure 1

Review

Jump to: Research

21 pages, 324 KiB  
Review
The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions
by Annamaria Cerantonio, Luigi Citrigno, Beatrice Maria Greco, Selene De Benedittis, Giuseppe Passarino, Raffaele Maletta, Antonio Qualtieri, Alberto Montesanto, Patrizia Spadafora and Francesca Cavalcanti
Int. J. Mol. Sci. 2024, 25(11), 6062; https://doi.org/10.3390/ijms25116062 - 31 May 2024
Viewed by 196
Abstract
Neurodegenerative diseases are progressive disorders that affect the central nervous system (CNS) and represent the major cause of premature death in the elderly. One of the possible determinants of neurodegeneration is the change in mitochondrial function and content. Altered levels of mitochondrial DNA [...] Read more.
Neurodegenerative diseases are progressive disorders that affect the central nervous system (CNS) and represent the major cause of premature death in the elderly. One of the possible determinants of neurodegeneration is the change in mitochondrial function and content. Altered levels of mitochondrial DNA copy number (mtDNA-CN) in biological fluids have been reported during both the early stages and progression of the diseases. In patients affected by neurodegenerative diseases, changes in mtDNA-CN levels appear to correlate with mitochondrial dysfunction, cognitive decline, disease progression, and ultimately therapeutic interventions. In this review, we report the main results published up to April 2024, regarding the evaluation of mtDNA-CN levels in blood samples from patients affected by Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s diseases (HD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). The aim is to show a probable link between mtDNA-CN changes and neurodegenerative disorders. Understanding the causes underlying this association could provide useful information on the molecular mechanisms involved in neurodegeneration and offer the development of new diagnostic approaches and therapeutic interventions. Full article
Back to TopTop